Depemokimab substantially reduced asthma exacerbations and improved respiratory quality of life and asthma control scores in patients with type 2 asthma and comorbid chronic rhinosinusitis with nasal ...

You need to be aware of seasonal allergies, which can lead to Anaphylaxis, asthma and other serious health conditions.

Science tells us our sense of smell is closely connected to our memories and emotions. That’s a function of the brain’s ...

CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma, on Monday said it has reported positive top-line Phase 3 ...

Company to pursue Phase 3 development strategy designed to deliver best-in-class efficacy with a high-dose quarterly regimen ...

The FDA approval for Ponlimsi is based on comprehensive evidence, including analytical and clinical data.

For many residents in Centennial Hills, Summerlin, Skye Canyon, Providence and Northwest Las Vegas, those environmental ...

Millions struggle with stubborn sinus trouble that feels like endless allergies, but the real cause might surprise you. It ...

Teva’s biosimilar, PONLIMSI™, is now FDA-approved across all indications of the reference product, Prolia ® (denosumab), to treat a variety of ...

Aurobindo Pharma unit CuraTeQ reports strong Phase 3 data for BP11 omalizumab biosimilar matching Xolair, supporting future ...

(Alliance News) - GSK PLC on Monday reported regulatory momentum in China for its drugs Exdensur and bepirovirsen. The pharmaceutical firm's shares were up 0.5% to 2,060.00 pence on Monday morning in ...

Experts say allergies are not only arriving early this year due to the unusual weather but they’re expected to linger longer ...